An integrated epidemiological and neural net model of the warfarin effect in managed care patients
David M Jacobs,1,2,* Filip Stefanovic,3,* Greg Wilton,2 Andres Gomez-Caminero,4 Jerome J Schentag1,2 1Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 2CPL Associates LLC, 3Department of Biomedical Engineering, University at Buffalo School of Eng...
Main Authors: | Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-05-01
|
Series: | Clinical Pharmacology : Advances and Applications |
Subjects: | |
Online Access: | https://www.dovepress.com/an-integrated-epidemiological-and-neural-net-model-of-the-warfarin-eff-peer-reviewed-article-CPAA |
Similar Items
-
The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01) -
Management of Patients Receiving Warfarin during Invasive Procedures and the Adverse Effects of Warfarin
by: Norikazu Watanabe, MD, et al.
Published: (2010-01-01) -
A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case–control study
by: Azoulay Laurent, et al.
Published: (2012-06-01) -
ANTICOAGULANT TREATMENT OF AF: FOCUS ON THE WARFARIN DOSAGE
by: Y. Kovbasniuk, et al.
Published: (2015-10-01) -
Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)